Contact Information:
Scribner Kidney Center
2150 North 107th Street, Suite 160
Box 358730
Seattle, WA 98133
Phone: (206) 363-5090
Fax:  (206) 363-6146
sahmad@u.washington.edu

Education and Training:
Nephrology Fellowship (1976-78)
University of Washington
Seattle, WA

Medicine Residency
(1968-71)
University of Allahabad
Uttar Pradesh, India

Medical School (1964-68)
University of Allahabad, M.L.N. Medical College
Uttar Pradesh, India

Site of Practice:
University of Washington Medical Center

 

suhail ahmad, MD

Professor of Medicine, Division of Nephrology
Chief Medical Officer, Northwest Kidney Centers
Director, Plasma Exchange & Dialysis Program, University of Washington Medical Center
Medical Director, Hypertension Clinic, University of Washington Medical Center

Specialty:  Clinical Hypertension, ASH Specialists Program
Research: Hemodialysis, Peritoneal Dialysis, Hypertension

Clinical Interests

  • Dialysis (Director of Dialysis and Apheresis Clinic, UWMC)
  • Hypertension (Director of Hypertension Clinic, UWMC)
  • Renal Stones

Research Interests

  • Hemodialysis: Areas related to technology; innovative products; short-term complications; long-term effects; survival; quality of life, etc.
  • Peritoneal Dialysis: Innovative technology; membrane kinetics; osmotic agents; infection; access
  • Hypertension; Pathophysiology of hypertension; management of hypertension; secondary hypertension

Current Research

  • Comparing the Combination of Aliskiren/Valsartan/HCTZ (300/320/25mg) to Aliskiren/HCTZ (300/25mg) in patients with essential hypertension not adequately responsive to HCTZ 25mg
  • Evaluation fo Cinacalcet HC1 Therapy to Lower Cardiovascular Events

Selected Publications

Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kid Int 38:912-918, 1990.

Johnson R, Ramsey PG, Gallagher N, Ahmad S: Fungal peritoneal infections in patients on chronic peritoneal dialysis. Am J Nephrol 5:169 175.

Ahmad S, Callan R, Cole JJ, Blagg CR: Dialysate made from dry chemicals using citrci acid increases dialysis dose. AM J Kidney Dis, 35(3):493-499, 2000.

Gallay BJ, Lei X, Toivola B, Ahmad S, Davidson RC: Screening for primary aldosteronism without discontinuing hypertensive medications: The Plasma Aldosterone-Renin Ration. Am J Kidney Dis 37(4):699-705, 2001.

Ahmad S: Manual of Clinical Dialysis. London, Science Press. 1999

Awards

  • James W. Haviland Award for Outstanding Achievement in Nephrology, 2006
  • Voted by peers to be included in "The Best Doctors in America," 2001-02, 1998, 1996 (Pacific Edition)
  • Teacher of the Year, UWMC, Division of Nephrology, 2001-02, 2000-01, 1999-2000

National and International Responsibilities

  • Member, International Society of Artificial Internal Organs, 2004-present
  • Founding Member, International Society of Hemodialysis, 2003-present
  • Member, International Society of Nephrology, 2002-present
  • Member, American Society of Hypertension, 1999-present
  • Member, King County Medical Society, 1998-present
  • Member, American Society of Artificial Internal Organs, 1980-present
  • Member, American Society of Nephrology, 1980-present
  • Member, Washingotn State Medical Association, 1980-present

[top of page]